1Othman MO, Wallace MB. Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) in 2011, a Western perspective [J]. Clin Res Hepatol Gastroenterol,2011,35(4): 288-294.
2Jung H, Bae JM, Choi MG,et al. Surgical outcome after incomplete endoscopic submucosal dissection of gastric cancer [J]. Br J Surg, 2011,98(1):73-78.
3Akasaka T, Nishida T, Tsutsui S, et al. Short-term outcomes of en- doscopic submucosal dissection (ESD) for early gastric neoplasm: multicenter survey by osaka university ESD study group [J]. Dig Endosc, 2011,23(1):73-77.
4Kim HH,Hyung WJ,Cho GS,et al.Morbidity and mortality of laparo- scopic gastrectomy versus open gastrectomy for gastric cancer: an interim report-a phase III multicenter, prospective,randomized Tri- al (KLASS Trial) [J]. Ann Surg, 2010,251(3):417-420.
5Shen L,Huang Y,Sun M,et al.Clinicopathological features associat- ed with lymph node metastasis in early gastric cancer:Analysis of a single-institution experience in china [J]. Can J Gastroenterol, 2009,23(5):353-356.
6Saka M,Katai H,Fukagawa T,et al.Recurrence in early gastric can- cer with lymph node metastasis [J]. Gastric Cancer,2008,11(4): 2i4-218.
7Kim JJ,Song KY,Hur H,et al.Lymph node micrometastasis in node negative early gastric cancer [J]. Eur J Surg Oncol,2009,35(4): 409-414.
9Kunisaki C, Takahashi M, Fukushima T,et al. The influence of stage migration on the comparison of surgical outcomes between D2 gastrectomy and D3 gastrectomy (para-aortic lymph node dis- section): a multi-institutional retrospective study [J]. Am J Surg, 2008,196(3):358-63.
2Kim MC, Kim KH, Kim HH, et al. Comparison of laparoscopy-assisted by conventional open distal gastrentony and extraperi gastric lymph node dissection in early gastric cancer.J Surg Oncol,2005,91 (1):90-94.
3Kitano S,Shiraishi N,Uyama I,et al.A multicenter study on oncologic outcome of laparoscopic gastrentony for early cancer in Japan.Ann Surg,2007,245 (1):68-72.
4Maruyama K,Kaminishi M,Hayashi K,et al.Gastric cancer treated in 1991 in Japan:data analysis of nationwide registry.Gastric Cancer,2006,9 (2):51-66.
5Cuschieri A,Weeden S,Fieldiny J,et al.Patient survival after D1 and D2 resections for gastric cancer:long- term results of the MRC randomized surgical trial.Surgical Co-operative Group.Br J Cancer,1999,79(9-10):1522 -1530.
6Songun I,Putter H,Kranenbarg EM,et al.Surgical treatment of gastric cancer:15-year follow-up results of the randomised nationwide Dutch D1 D2 trail.Lancet Oncol,2010,11 (5):439-449.
7Wu CW, Hsiung CA,Lo SS,et al.Nodal dissection for patients with gastric cancer: a randomised controlled trail.Lancet Oncol,2006,7 (4):309-315.
8Edwards P, Blackshaw GR, Lewis WG, et al.Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma.Br J Cancer,2004,90 (10):1888-1892.
9Yu W, Choi GS, Chung HY.Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer.Br J Surg,2006,93(5):559-563.
8Wang J, Jia R, Zhang Y, et al. The role of Bax and Bcl-2 in gemcitabine-mediated cytotoxicity in uveal melanoma cells [ J ]. Tumour Biol, 2014,35 (2) :1169.
